Actiza Pharmaceutical Private Limited

[5-(4-Methoxy-2,3,6-trimethylphenyl)-3-methyl-2,4-pentadien-1-yl]triphenylphosphonium bromide is primarily used as a research chemical compound and as an API for synthesizing acitretin.

4-Methylsulfonylphenylacetic acid (4MSP) is an important active pharmaceutical ingredient (API) used as a key intermediate in the synthesis of various therapeutic compounds. It plays a significant role in the development of non-steroidal anti-inflammatory drugs (NSAIDs) and other analgesic agents due to its favorable chemical structure, which enhances drug efficacy and stability. The presence of the methylsulfonyl group contributes to its anti-inflammatory properties, making it a valuable component in formulations aimed at treating pain, swelling, and inflammation. Additionally, 4MSP is utilized in pharmaceutical research for the design and production of new drug candidates, highlighting its relevance in medicinal chemistry and drug development processes